According to Odaily, shares of Hong Kong-listed company Leading Pharma Biotech (00399) experienced a significant surge during early trading, with prices rising nearly 240% at one point. The stock reached a peak of 0.7 HKD before settling around 0.34 HKD. This increase follows the company's announcement of its intention to acquire full ownership of the blockchain project Conflux, aiming to expand its presence in the blockchain sector. Two founding members of Conflux currently serve as executive directors at Leading Pharma Biotech.